Scott Reynolds has deep experience in pharmaceutical development, with expertise in drug formulation, chemical process development, and vaccines. During his 31 years in leadership roles in Merck’s Research Laboratories and Manufacturing divisions, Scott led groups responsible for a broad segment of the product development life cycle, from early development and clinical supply through manufacturing plant start-up, product launch, and commercial product support. Since his retirement from Merck in 2015, he has consulted with clients in the pharmaceutical and biotechnology industries on topics related to Chemistry, Manufacturing, and Controls (CMC) development and manufacturing support. He currently leads the CMC Team at Elion.